|What's the one word cancer patients don't want to hear?|
|Written by Don Dizon, MD | KevinMD|
|Tuesday, 01 November 2016 11:51|
She had come to see me in consultation. A professor at a local university, she was well until four years earlier when she developed abdominal bloating and pain - telltale signs of ovarian cancer. Surgery followed, then adjuvant chemotherapy with intraperitoneal treatments. ("Terrible regimen," she said.) She was fine for two years, until the bloating recurred heralding recurrent disease. Surgery followed and she sought out a second opinion about more therapy. "My oncologist recommended more of the same - carboplatin and paclitaxel. But it didn't cure me the last time, so it doesn't make sense to me that this would be the best treatment for me now. I wanted to know what else was out there," she told me.
We talked about well-established concepts in the approach to recurrent ovarian cancer, such as platinum sensitivity, and how that predicts success to retreatment with carboplatin. I explained why I thought her doctors were right in their suggested treatments, and reviewed other platinum-based combinations she could receive. We also reviewed clinical trials and novel treatments, such as bevacizumab.
|Last Updated on Tuesday, 01 November 2016 11:52|
Website design, development, and hosting provided by